Scientific Literature Search

Source record

Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy.

Tan CC, Yu JT, Tan MS, Jiang T, Zhu XC, Tan L.

Neurobiol Aging · 2013-11-28

DOI: 10.1016/j.neurobiolaging.2013.11.019PMID: 24360503

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Chronic monoamine oxidase-B inhibitor treatment blocks monoamine oxidase-A enzyme activity.

Bartl J, Müller T, Grünblatt E, Gerlach M, Riederer P.

J Neural Transm (Vienna) · 2013-11-23

DOI: 10.1007/s00702-013-1120-zPMID: 24272680

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Levodopa reinstates connectivity from prefrontal to premotor cortex during externally paced movement in Parkinson's disease.

Herz DM, Siebner HR, Hulme OJ, Florin E, Christensen MS, Timmermann L.

Neuroimage · 2013-11-22

DOI: 10.1016/j.neuroimage.2013.11.023PMID: 24269570

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson's disease experiencing mild wearing-off: a randomised, double-blind trial.

Tolosa E, Hernández B, Linazasoro G, López-Lozano JJ, Mir P, Marey J, Kulisevsky J.

J Neural Transm (Vienna) · 2013-11-20

DOI: 10.1007/s00702-013-1114-xPMID: 24253234

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Swallowing improvement after levodopa treatment in idiopathic Parkinson's disease: lack of evidence. Authors' reply.

Melo A, Monteiro L.

Parkinsonism Relat Disord · 2013-11-18

DOI: 10.1016/j.parkreldis.2013.10.028PMID: 24300049

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

Klyachko NL, Haney MJ, Zhao Y, Manickam DS, Mahajan V, Suresh P, Hingtgen SD, Mosley RL, Gendelman HE, Kabanov AV, Batrakova EV.

Nanomedicine (Lond) · 2013-11-18

DOI: 10.2217/nnm.13.115PMID: 24237263

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

L-DOPA-treatment in primates disrupts the expression of A(2A) adenosine-CB(1) cannabinoid-D(2) dopamine receptor heteromers in the caudate nucleus.

Bonaventura J, Rico AJ, Moreno E, Sierra S, Sánchez M, Luquin N, Farré D, Müller CE, Martínez-Pinilla E, Cortés A, Mallol J, Armentero MT, Pinna A, Canela EI, Lluís C, McCormick PJ, Lanciego JL, Casadó V, Franco R.

Neuropharmacology · 2013-11-11

DOI: 10.1016/j.neuropharm.2013.10.036PMID: 24230991

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Excitatory deep repetitive transcranial magnetic stimulation with H-coil as add-on treatment of motor symptoms in Parkinson's disease: an open label, pilot study.

Spagnolo F, Volonté MA, Fichera M, Chieffo R, Houdayer E, Bianco M, Coppi E, Nuara A, Straffi L, Di Maggio G, Ferrari L, Dalla Libera D, Velikova S, Comi G, Zangen A, Leocani L.

Brain Stimul · 2013-10-29

DOI: 10.1016/j.brs.2013.10.007PMID: 24300835

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Association of common genetic variants of HOMER1 gene with levodopa adverse effects in Parkinson's disease patients.

Schumacher-Schuh AF, Altmann V, Rieck M, Tovo-Rodrigues L, Monte TL, Callegari-Jacques SM, Medeiros MS, Rieder CR, Hutz MH.

Pharmacogenomics J · 2013-10-15

DOI: 10.1038/tpj.2013.37PMID: 24126708

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Thalamic stimulation alleviates levodopa-resistant rigidity in a patient with non-Parkinson's disease parkinsonian syndrome.

Yamada K, Hamasaki T, Kuratsu J.

J Clin Neurosci · 2013-10-11

DOI: 10.1016/j.jocn.2013.07.036PMID: 24291482

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Open access

Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis.

Rizzo F, Riboldi G, Salani S, Nizzardo M, Simone C, Corti S, Hedlund E.

Cell Mol Life Sci · 2013-10-08

DOI: 10.1007/s00018-013-1480-4PMID: 24100629

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Source record

Modulation of corticomotor excitability after maximal or sustainable-rate repetitive finger movement is impaired in Parkinson's disease and is reversed by levodopa.

Teo WP, Rodrigues JP, Mastaglia FL, Thickbroom GW.

Clin Neurophysiol · 2013-10-01

DOI: 10.1016/j.clinph.2013.09.004PMID: 24095151

A bibliographic record traceable to Europe PMC.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

10.361 articles found

Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy.

Chronic monoamine oxidase-B inhibitor treatment blocks monoamine oxidase-A enzyme activity.

Levodopa reinstates connectivity from prefrontal to premotor cortex during externally paced movement in Parkinson's disease.

Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson's disease experiencing mild wearing-off: a randomised, double-blind trial.

Swallowing improvement after levodopa treatment in idiopathic Parkinson's disease: lack of evidence. Authors' reply.

Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

L-DOPA-treatment in primates disrupts the expression of A(2A) adenosine-CB(1) cannabinoid-D(2) dopamine receptor heteromers in the caudate nucleus.

Excitatory deep repetitive transcranial magnetic stimulation with H-coil as add-on treatment of motor symptoms in Parkinson's disease: an open label, pilot study.

Association of common genetic variants of HOMER1 gene with levodopa adverse effects in Parkinson's disease patients.

Thalamic stimulation alleviates levodopa-resistant rigidity in a patient with non-Parkinson's disease parkinsonian syndrome.

Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis.

Modulation of corticomotor excitability after maximal or sustainable-rate repetitive finger movement is impaired in Parkinson's disease and is reversed by levodopa.

Filters